--- title: "Jamieson Wellness Sets Date for Q4 and Full-Year 2025 Results and Investor Call" type: "News" locale: "en" url: "https://longbridge.com/en/news/275819580.md" description: "Jamieson Wellness Inc. will release its Q4 and full-year 2025 financial results on February 26, 2026, followed by an investor call. The company emphasizes transparency and engagement with stakeholders, aiming to bolster investor confidence. Despite strong financial performance and growth in branded revenue, analysts have mixed views on TSE:JWEL stock, with a current rating of Buy and a price target of C$36.00, while some indicators suggest a bearish trend and high valuation concerns. Jamieson Wellness is a leading Canadian producer of vitamins and supplements, operating in over 50 countries." datetime: "2026-02-12T22:47:13.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/275819580.md) - [en](https://longbridge.com/en/news/275819580.md) - [zh-HK](https://longbridge.com/zh-HK/news/275819580.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275819580.md) | [繁體中文](https://longbridge.com/zh-HK/news/275819580.md) # Jamieson Wellness Sets Date for Q4 and Full-Year 2025 Results and Investor Call ### Valentine's Day Sale - 70% Off - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential An announcement from Jamieson Wellness Inc ( (TSE:JWEL) ) is now available. Jamieson Wellness Inc., a Toronto-based producer of vitamins, minerals, supplements and sports nutrition products under brands such as Jamieson, youtheory, Progressive, Smart Solutions, Iron Vegan and Precision, sells its portfolio across more than 50 countries and emphasizes adherence to UN Global Compact principles. The company has announced it will release its fourth quarter and full-year 2025 financial results after markets close on February 26, 2026, followed by an investor conference call and webcast that will provide stakeholders with detailed insight into its recent performance and strategic progress. The scheduled conference call and accompanying replay and webcast access underscore Jamieson Wellness’s efforts to maintain transparency and engagement with investors and analysts regarding its operational and financial trajectory. By formally setting the results date and communication plan well in advance, the company signals disciplined disclosure practices that may help support investor confidence and reinforce its positioning in the competitive global natural health and wellness market. The most recent analyst rating on (TSE:JWEL) stock is a Buy with a C$36.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page. **Spark’s Take on TSE:JWEL Stock** According to Spark, TipRanks’ AI Analyst, TSE:JWEL is a Neutral. Jamieson Wellness Inc. shows strong financial performance and positive earnings call results, with significant growth in branded revenue and international markets. However, technical indicators suggest a bearish trend, and the valuation appears high. The company’s stable financials and growth prospects are offset by technical weaknesses and valuation concerns. To see Spark’s full report on TSE:JWEL stock, click here. **More about Jamieson Wellness Inc** Jamieson Wellness Inc. is a Canadian natural health products company, best known for its Jamieson brand, the country’s leading vitamins, minerals and supplements label, and the U.S.-focused youtheory lifestyle brand, with distribution in more than 50 countries worldwide. The company also markets additional VMS and sports nutrition brands, including Progressive, Smart Solutions, Iron Vegan and Precision, and positions itself as a responsible business through participation in the United Nations Global Compact. **Average Trading Volume:** 80,460 **Technical Sentiment Signal:** Buy **Current Market Cap:** C$1.53B Find detailed analytics on JWEL stock on TipRanks’ Stock Analysis page. ### Related Stocks - [Jowell Global Ltd. (JWEL.US)](https://longbridge.com/en/quote/JWEL.US.md) ## Related News & Research - [Stifel Nicolaus Sticks to Its Buy Rating for Jamieson Wellness Inc (JWEL)](https://longbridge.com/en/news/276010618.md) - [Lunakai Gummy Supplements Officially Available in AlchePharma Stores](https://longbridge.com/en/news/281372641.md) - [VSBLTY to Raise Up to C$7 Million in Private Placement, Grants New RSUs](https://longbridge.com/en/news/281104034.md) - [AutoCanada (TSE:ACQ) Insider Samuel Cochrane Purchases 795 Shares of Stock](https://longbridge.com/en/news/281154255.md) - [12:16 ETLunakai Highlights Public Health and Stress Awareness in April](https://longbridge.com/en/news/281400535.md)